Sigma Healthcare Limited Financials

Market Capitalization A$2.06 Billion as of July 1, 2024

Valuations Metrics as of May. 5, 2024

Trailing PE	121.50
Forward PE	31.38
Price to Sales TTM	A$0.62
Price to Book MRQ	A$2.27
Enterprise to Revenue	0.53
Enterprise to EBITDA	38.29

Financial Reports as of Jan. 31, 2024

Financials

Fiscal Year Ends	2024-01-31
Most Recent Quarter	2024-01-31
Profit Margin	0.14%
Operating Margin	0.55%
Return on Assets TTM	1.54%
Return on Equity TTM	0.79%

Income Statement

Revenue TTM	A$3,322,057,984
Revenue per Share TTM	A$3.24
Quarterly Revenue Growth	-10.10%
Gross Profit TTM	A$271,850,000
EBITDA	A$53,250,000
Net Income to Common TTM	A$4,509,000
Diluted EPS TTM	A$0.00
Quarterly Earnings Growth YoY	%

Balance Sheet

Total Cash MRQ	A$356,496,000
Total Cash per Share MRQ	A$0.23
Total Debt MRQ	A$
Total Debt to Equity MRQ	15.66
Current Ratio MRQ	2.46
Book Value per Share MRQ	A$0.55

Cash Flow

Operating Cash Flow TTM	A$41,965,000
Levered Free Cash Flow TTM	A$46,068,500

SIG Stock Info as of May. 5, 2024

Stock Statistics

Shares Outstanding	1,631,869,952
Float Shares	1,248,777,497
Avg 10 Volume	4,530,568
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	3.62%
% Held by Institutions	40.13%

Stock Price Summary

Beta	0.26
Fifty Two Week Low	A$0.63
Fifty Two Week High	A$1.35
Fifty Two Week Change	45.95%
Day 50 MA	A$1.23
Day 200 MA	A$0.91

Dividends and Splits

Forward Annual Dividend Rate	A$0.02
Forward Annual Dividend Yield	1.54%
Trailing Annual Dividend Rate	A$0.01
Trailing Annual Dividend Yield	0.77%
Payout Ratio	220.50%
Dividend Date
Ex Dividend Date	2024-03-28
Last Split Factor
Last Split Date	2009-09-10